Amplification and over-expression of OZF, a gene encoding a zinc finger protein, in human pancreatic carcinomas

International Journal of Cancer

Volumn 80, Issue 3, 1999, Pages 369-372

  Ferbus, Didier ^a   Fléchon, Aude ^a   Muleris, Martine ^a   Li, Yong ^b   Hanash, Samir ^b   Terris, Benoît ^c   Hammel, Pascal ^c   Pibouin, Laurence ^a   Dutrillaux, Bernard ^a   Goubin, Gérard ^a  

^a INSTITUT CURIE   (France)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ZINC FINGER PROTEIN;

ADULT; ARTICLE; CHROMOSOME 19Q; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS CARCINOMA; PRIORITY JOURNAL; TUMOR CELL LINE;

BLOTTING, WESTERN; CARCINOMA, GIANT CELL; DNA-BINDING PROTEINS; GENE AMPLIFICATION; HUMANS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; RNA-BINDING PROTEINS; TUMOR CELLS, CULTURED;

EID: 0345148781     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990129)80:3<369::AID-IJC6>3.0.CO;2-Y     Document Type: Article

References (28)

1. AKITA, E.M. and NAKAI, S., Immunoglobulins from egg yolk: isolation and purification. J. Food Sci., 57, 629-634 (1992).
2. ALMOGUERA, C., SHIBATA, D., FORRESTER, K., MARTIN, J., ARNHEIM, N. and PERUCHO, M., Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53, 549-554 (1988).
3. CALDAS, C., HAHN, S., DA COSTA, L., EDSTON, M., SCHUTTE, M., SEYMOUR, A., WEINSTEIN, C., HRUBAN, R., YEO, C. and KERN, S., Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature (Genet.), 8, 27-32 (1994).
4. CHENG, J.Q., GODWIN, A.K., BELLACOSA, A., TAGUCHI, T., FRANKE, T.F., HAMILTON, T.C., TSCHLIS, P.N. and TESTA, J.R., AKT2, a putative oncogene encoding a member of a family of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc. nat. Acad. Sci. (Wash.), 89, 9267-9271 (1992).
5. CHENG, J.Q., RUGGERI, B., KLEIN, W.M., SONODA, G., ALTOMARE, D.A., WATSON, D.K. and TESTA, J.R., Amplification of AKT2 in human pancreatic cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. nat. Acad. Sci. (Wash.), 93, 3636-3641 (1996).
6. CURTIS, L.J., LI, Y., GERBAULT-SEUREAU, M., KUICK, R., DUTRILLAUX, A.M., GOUBIN, G., FAWCETT, J., CRAM, S., DUTRILLAUX, B., HANASH, S. and MULERIS, M., Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines. Genomics 53, 42-55 (1998).
7. FERBUS, D., LE CHALONY, C., PROSPERI, M.-T., MULERIS, M., VINCENT-SALOMON, A. and GOUBIN, G., Identification, nuclear localisation, and binding activities of OZF, a human protein solely composed of zinc-finger motifs. Europ. J. Biochem., 236, 991-995 (1996).
8. GANSAUGE, S., GANSAUGE, F., RAMADANI, M., STOBBE, H., RAU, B., HARADA, N. and BEGER, H.G., Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res., 57, 1634-1637 (1997).
9. GRIFFIN, C.A., HRUBAN, R.H., MORSBERGER, L.A., ELLINGHAM, T., LONG, P.P., JAFFEE, E.M., HAUDA, K.M., BOHLANDER, S.K. and YEO, C.J., Consistent chromosome abnormalities in adenocarcinoma of the pancreas. Cancer Res., 55, 2394-2399 (1995).
10. HAHN, S.A., SCHUTTE, M., HOQUE, A.T., MOSKALUK, C.A., DA COSTA, L.T., ROZENBLUM, E., WEINSTEIN, C.L., FISCHER, A., YEO, C.J., HRUBAN, R.H. and KERN, S.E., DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science, 271, 350-353 (1996).
11. JOHANSSON, B., BARDI, G., HEIM, S., MANDAHL, N., MERTENS, F., BAK-JENSEN, E., ANDREN-SANDBERG, A. and MITELMAN, F., Nonrandom chromosomal rearrangements in pancreatic carcinomas. Cancer, 69, 1674-1681 (1992).
12. KOBRIN, M.S., YAMANAKA, Y. FRIESS, H., LOPEZ, M.E. and KORC, M., Aberrant expression of type 1 fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res., 53, 4741-4744 (1993).
13. KORC, M., CHANDRASEKAR, B., YAMANAKA, Y., FRIESS, H., BUCHIER, M. and BEGER, H.G., Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J. clin. Invest., 90, 1352-1360 (1992).
14. LE CHALONY, C., APIOU, F. PIBOUIN, L., DUTRILLAUX, B. and GOUBIN, G., Constitutive amplification of a zinc finger protein gene in cattle. DNA Cell Biol., 15, 83-88 (1996).
15. LE CHALONY, C., PROSPÉRI, M.-T., HALUZA, R., APIOU, F., DUTRILLAUX, B. and GOUBIN, G., The OZF gene encodes a protein consisting essentially of zinc finger motifs. J. mol. Biol., 236, 399-404 (1994).
16. LEMOINE, N.R., HUGHES, C.M., BARTON, C.M., POULSOM, R., JEFFERY, R.E., KLOPPEL, G., HALL, P.A. and GULLICK, W.J., The epidermal growth factor receptor in human pancreatic cancer. J. Pathol., 166, 7-12 (1992).
17. LEUNG, H.Y., GULLICK, W.J. and LEMOINE, N.R., Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int. J. Cancer, 59, 667-675 (1994).
18. MIWA, W., YASUDA, J., MURAKAMI, Y., YASHIMA, K., SUGANO, K., SEKINE, T., KONO, A., EGAWA, S., YAMAGUCHI, K., HAYASHIZAKI, Y. and SEKIYA, T., Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer. Biochem. biophys. Res. Comm., 225, 968-974 (1996).
19. PELLEGATA, N., SESSA, F., RENAULT, B., BONATO, M., LEONE, E., SOLCIA, E. and RANZANI, G., K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res., 54, 1556-1560 (1994).
20. PRAT, M., NARSIMHAN, R.P., CREPALDI, T., NICOTRA, M.R., NATALI, P.G. and COMOGLIO, P.M., The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int. J. Cancer, 49, 323-328 (1991).
21. PRIGENT, S.A., LEMOINE, N.R., HUGHES, C.M., PLOWMAN, G.D., SELDEN, C. and GULLICK, W.J., Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene, 7, 1273-1278 (1992).
22. PROSPÉRI, M.-T., FERBUS, D., KARCZINSKI, I. and GOUBIN, G., A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins. J. biol. Chem., 268, 11050-11056 (1993).
23. REDSTON, M.S., CALDAS, C., SEYMOUR, A.B., HRUBAN, R.H., DA COSTA, L., YEO, C.J. and KERN, S.E., p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res., 54, 3025-3033 (1994).
24. SAMBROOK, J., FRISCHT, E.F. and MANIATIS, T., Molecular cloning: a laboratory manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
25. SCARPA, A., CAPELLI, P., MUKAI, K., ZAMBANI, G., ODA, T., IACONO, C. and HIROHASHI, S., Pancreatic adenocarcinomas frequently show p53 gene mutations. Amer. J. Pathol., 142, 1534-1543 (1993).
26. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. and PRESS, M.F., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712 (1989).
27. TERRIS, B., BALDIN, V., DUBOIS, S., DEGOTT, C., FLÉJOU, J.F., HÉNIN, D. and DEJEAN, A., PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res., 55, 1590-1597 (1995).
28. THE HUMAN GENE MAP, National Center for Biotechnology Information, National Institutes of Health, Bethesda, MD, http://www.ncbi.nlm.nih.gov/SCIENCE96/(1997).